Dendreon’s Dave Urdal on Truly Novel Cancer Drugs: Science & Technology Discovery Series

Dave Urdal, the chief scientific officer of Seattle-based Dendreon, is the featured speaker at the Technology Alliance’s Science & Technology Discovery Series breakfast meeting on December 10. The Technology Alliance asks attendees to please RSVP by Noon on Monday, Dec. 6. For more information about how to register, click here.